Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-14, Stock:LLY, The news for the past five days is as follows:
2018-12-07: NEWS1: Mallinckrodt (MNK) to Separate Generics & Branded Businesses.NEWS2: Mallinckrodt (MNK) to Separate Generics & Branded Businesses.NEWS3: 7 Stocks to Buy to Survive a Bear Market.NEWS4: 7 Stocks to Buy to Survive a Bear Market.NEWS5: Mallinckrodt (MNK) to Separate Generics & Branded Businesses.NEWS6: 7 Stocks to Buy to Survive a Bear Market.
2018-12-10: NEWS1: The Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company.NEWS2: The Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company.NEWS3: HDV, MO, MMM, LLY: Large Inflows Detected at ETF.NEWS4: HDV, MO, MMM, LLY: Large Inflows Detected at ETF.NEWS5: The Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company.
2018-12-11: NEWS1: What Seattle Genetics’ Bottom-Line Trend Indicates.NEWS2: Understanding Seattle Genetics’ Operational Performance.NEWS3: How’s Seattle Genetics Positioned?.NEWS4: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS5: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS6: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS7: AXON Throws In The Towel On Nelotanserin, MNLO On Watch, VYGR Sails Ahead.NEWS8: AXON Throws In The Towel On Nelotanserin, MNLO On Watch, VYGR Sails Ahead.
2018-12-12: NEWS1: Lilly partners with AC Immune for Alzheimer's treatment.NEWS2: Lilly partners with AC Immune for Alzheimer's treatment.NEWS3: AC Immune and Lilly Announce License and Collaboration Agreement.NEWS4: Lilly and AC Immune Announce License and Collaboration Agreement.NEWS5: Lilly And AC Immune Enter Into License And Collaboration Agreement.NEWS6: Lilly And AC Immune Enter Into License And Collaboration Agreement.
2018-12-13: NEWS1: A Closer Look at Biogen’s Gross Margin Trends.NEWS2: Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?.NEWS3: Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?.NEWS4: Stocks - Ciena Jumps in Premarket, Apple Gains, Tailored Brands Crashes.NEWS5: Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug.NEWS6: Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug.NEWS7: Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?.NEWS8: Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug.NEWS9: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS10: FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE).NEWS11: Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease.NEWS12: Eli Lilly : FDA Grants Fast Track Designation To Baricitinib Development Program.NEWS13: Eli Lilly : FDA Grants Fast Track Designation To Baricitinib Development Program.

Answer: Decrease